ClinicalTrials.Veeva

Menu

Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases

U

Universidade Estadual de Londrina

Status

Unknown

Conditions

Chronic Obstructive Pulmonary Disease
Asthma Chronic
Idiopathic Pulmonary Fibrosis

Study type

Observational

Funder types

Other

Identifiers

NCT04693975
PIDS-PC

Details and patient eligibility

About

Social distancing during the COVID-19 pandemic could lead to clinical and functional deterioration of people living with chronic respiratory diseases (CRD). As they are considered risk group for COVID-19, it is not recommended that they leave their house and have interaction with people outside. Thus, most of them have not been attend Pulmonary Rehabilitation sections since the beginning of pandemic, neither exercising outdoor, experiencing drastic restrictions in their activities of daily living.

It is well known that low level of physical activity in daily life (PADL) in this population is related to poor prognosis, including higher chance of hospitalization due to exacerbation and mortality. Therefore, the aim of this study is to evaluate the short- and mid-term impact of the COVID-19 pandemic on the clinical, physical and functional conditions and the PADL level of people living with CRD (chronic obstructive pulmonary disease, asthma and interstitial lung diseases).

Participants will be assessed during the social isolation period and they will be reassessed immediately after release from social isolation. Thus, the subjects will be followed-up during 12 months to record symptoms, functional status, quality of life, exacerbations and hospitalizations.

The researchers' hypothesis is that those patients will present very low level of PADL in association to sedentarism, poor functional status, more symptoms of dyspnoea, anxiety and depression, poor sleep quality and, consequently, will present more episodes of acute exacerbation of the disease and more hospital admission during the study protocol.

Enrollment

94 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of chronic obstructive pulmonary disease, asthma or interstitial lung disease;
  • Absence of any severe and/or unstable cardiac disease;
  • Absence of any orthopedic or neuromuscular condition that limits physical activity in daily life.

Exclusion criteria

  • Desire to leave the study at any time;
  • Infection with SARS-CoV-2 during the study protocol.

Trial contacts and locations

1

Loading...

Central trial contact

Nidia A Hernandes, PhD; Fabio Pitta, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems